The Infant Formula Industry Analysis in United States is valued at USD 6.56 billion in 2025 and is expected to reach USD 9.08 billion by 2035. This represents a CAGR of 3.3% from 2025 to 2035. The market’s consistent expansion reflects both consumer demand and innovation within the sector, driven by changing demographics, evolving parenting lifestyles, and increased awareness about the importance of early-life nutrition.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 6.56 billion |
| Industry Value (2035F) | USD 9.08 billion |
| CAGR (2025 to 2035) | 3.3% |
A primary driving force behind this market growth is the rising health consciousness among parents and caregivers, leading to an increasing demand for high-quality, nutritionally rich infant formula. As breastfeeding is not always a viable option for all families, due to medical conditions, personal choice, or lifestyle factors, infant formula is becoming a critical supplement or alternative.
Modern consumers are particularly interested in formulations that closely mimic the nutritional composition of breast milk, emphasizing the inclusion of essential nutrients such as DHA, ARA, prebiotics, and probiotics to support infants’ cognitive and immune development. Additionally, formulas catering to specific dietary needs, such as hypoallergenic, lactose-free, and plant-based options, are gaining traction and contributing to overall market expansion.
Starting milk formula will dominate the product type segment, holding 60% of the market share by 2025. Specialty outlet will lead the distribution channel segment with a 45% share.
Another notable factor accelerating growth is the digital transformation in retail channels, especially through direct-to-consumer (DTC) platforms and e-commerce. The increased accessibility and convenience of purchasing infant formula online have significantly enhanced market penetration, especially among tech-savvy and urban parents.
Furthermore, regulatory oversight by the USA Food and Drug Administration (FDA) ensures high safety standards, bolstering consumer trust. Government programs such as WIC (Women, Infants, and Children) continue to support access to infant formula for low-income families, further reinforcing market stability. Despite challenges like supply chain issues, raw material cost volatility, and global competition, the industry remains resilient and is expected to continue its upward trajectory through 2035.
Based on structure, the industry is divided into starting milk formula and follow-on milk formula. starting milk formula is further segmented into standard, comfort, and hypoallergenic formulas and the follow-on milk formula 1st and 2nd follow formula. By category, starting milk formula segment holds the biggest industry share, with an estimated industry share of around 60% in 2025.
Suitable for babies 0-6 months old, this Formula offers crucial nutrients that mimic breast milk composition with the addition of DHA, ARA, and prebiotics. The rise in working mothers and a proliferation of breastfeeding problems have increased the demand for infant formula as a substitute.
The industry has major brands like Similac (Abbott), Enfamil (Reckitt Benckiser), and Gerber (Nestlé) with specialized formulations for lactose-free and organic products. The FDA has also introduced strict quality standards at various levels of production to enhance further consumer safety and nutritional adequacy, which helps to boost consumer confidence.
Follow-on milk formula is expected to be the leading segment with approximately 40% volume share during the enhanced consumption phase between 2023 and 2025 as the baby moves from 6 to 12 months of age when solid food consumption increases.
This Formula provides more iron, calcium, and essential vitamins to support healthy growth and development. Parents looking for nutritionally enhanced formulas tend to choose follow-on versions to add to their little one's diet. Major players like Danone (Aptamil) and Earth's Best are capitalizing on the trend toward clean-label infant nutrition by offering organic and non-GMO formulas.
The distribution channel segment of the industry is categorized into specialty outlets and supermarkets, all of which support the industry by making a wide variety of products available to consumers at the right time, making it easy for them to decide whether or not to purchase a product.
In 2025, specialty channels represent a 45% share of the infant formula industry; this is bolstered by parents' need for expert recommendations and premium formulations. Others, such as baby specialty stores, pharmacies, and health-focused retailers, find parents looking for personal guidance on choosing a formula.
Specialty outlets often carry organic, hypoallergenic, and medical-grade formulas, for example, Neocate (Nutricia) and Similac Alimentum (Abbott), designed for infants with allergies or digestive sensitivities. Moreover, e-commerce platforms such as Amazon, Buy Buy Baby, and the online stores of The Honest Company have experienced an increase in direct-to-consumer sales, with subscription-style purchasing and home delivery options providing additional access to specialized infant nutrition products.
Supermarkets represent the majority of the retail channel and are projected to account for around 55% of the industry share by 2025 on the basis of convenience and cost-effectiveness. Big retailers like Walmart, Target, and Kroger sell a number of common infant formula brands, including Similac, Enfamil, and Gerber, often at discounted and bundled prices.
The selection of private-label formulas, such as Parent's Choice (Walmart) and Up & Up (Target), is enticing to the price-sensitive consumer. Also, there are government assistance programs, such as WIC (Women, Infants and Children) that help get formula purchases in supermarkets which promotes more sales.
The industry is transforming rapidly because of the major factors such as heightened parental consciousness, surging organic and specialty formula demand, and tight regulatory compliance. Organic and hypoallergenic formulas are being favored more by parents based on issues relating to artificial additives, allergens, and digestive issues.
Organic baby formula is showing robust growth through the clean-label trend and a desire for non-GMO, hormone-free content. Hypoallergenic and specialty formula address babies suffering from lactose intolerance, reflux, and other health conditions that drive purchasing choices based on the pediatrician.
The toddler formula segment is expanding as companies promote nutritional supplementation post-infancy. Price sensitivity, however, is a key factor, particularly among middle-income households. Regulation compliance is stringent, with the FDA closely monitoring ingredients and nutritional content. In general, the industry will expand as companies focus on innovation, premiumization, and targeting particular infant health conditions while navigating regulatory challenges.
The expansion of the industry is chiefly attributable to the increased interest in quality, nutritious products. Nevertheless, strict adherence to the FDA's guidelines and the need to follow the evolving safety protocols prove to be the main headaches of the companies. So, they must carry out stringent quality checks, get the necessary approvals, and observe rigorous labeling and formulation guidelines in addition to all that if they want to get the consumer trust and regulatory approval.
Consumers increasingly prefer organic, non-GMO, and plant-based infant formulas; thus, the industry experiences a sharp increase in demand for new product formulations. However, prevalent misunderstanding regarding the alternative of ingredients and distrust of synthetic nutrients can affect consumers' decisions in the opposite direction. Companies need to emphasize transparent marketing, scientific facts, and consumer education as the means to promote product acceptance.
Intense rivalry between multinational firms, private labels, and new companies results in price pressure and differentiation. To induce their industry shares, organizations have to advertise their best features, such as the inclusion of immune-enhancing elements, digestive benefits, and infant-specific sophisticated profiles of nutrition.
Inflation and household income variations are the key factors that influence consumers' buying habits. For companies to achieve long-term growth, they need to consider executing the company in a cost-efficient way, growing their retail and e-commerce distribution channels, and, in the end, eating well and drinking cheap - all while keeping affordability and quality intact.
The United States infant formula market is moderately consolidated, with prominent players including Abbott Laboratories, Nestlé S.A., Danone, Reckitt Benckiser Group PLC, and Perrigo Company PLC. These companies lead the market by offering a wide range of nutritionally advanced, specialty, and medically tailored infant formulas that cater to various dietary and developmental needs.
For instance, Abbott Laboratories offers science-backed infant formulas such as Similac, which are enriched with immune-supporting ingredients like HMO (human milk oligosaccharides). Nestlé S.A., through its Gerber brand, emphasizes organic and non-GMO formulations that appeal to health-conscious parents.
Danone, with its Aptamil and Nutricia lines, focuses on early-life nutrition supported by clinical research, while Reckitt Benckiser Group PLC markets Enfamil, a trusted formula enriched with brain-nourishing nutrients like DHA. Perrigo Company PLC provides affordable store-brand infant formulas, increasing access for value-driven consumers without compromising nutritional quality.
Abbott Laboratories (30-35%)
Industry leader through rebuilding consumer confidence with augmented production capacity and new safety measures.
Reckitt Benckiser (25-30%)
Owns hospital-recommended formulas, investing in premium infant nutrition and hypoallergenic versions.
Nestlé (10-14%)
Building out its organic and plant-based business, Gerber's formula range is being built as consumers demand clean-label products.
Perrigo Nutritionals (8-12%)
Top store-brand vendor, providing cheap substitutes for upscale brands, profiting from frugal consumers.
Bobbie (5-8%)
Direct-to-consumer upstart, taking advantage of USA consumers' appetite for European-style organic formulas.
Other Key Players
By product type, the industry is classified as starting milk formula, follow-on milk formula, and special milk formula.
By distribution channel, the industry is classified as specialty outlets, supermarkets, online stores, pharmacy stores, and others.
By state, the industry is segmented as California, Texas, Florida, New York, Illinois, Ohio, North Carolina, Michigan, Colorado, Wisconsin, and Washington.
The industry is expected to generate USD 6.56 billion in revenue by 2025.
The industry is projected to reach USD 9.08 billion by 2035, growing at a CAGR of 3.3%.
Key players include Abbott Laboratories (Similac), Reckitt Benckiser (Enfamil), Nestlé (Gerber, Nido), Perrigo Nutritionals, Bobbie, Kendamil, Bubs Australia, Else Nutrition, Earth’s Best (Hain Celestial), and ByHeart.
Rising awareness of infant nutrition, increasing demand for organic and non-GMO formulas, and the growing number of working mothers opting for formula feeding are key growth drivers.
Cow’s milk-based infant formula dominates due to its close resemblance to human breast milk, followed by specialty formulas catering to lactose intolerance and hypoallergenic needs.
Explore Similar Insights
Infant Formula Industry Analysis in United States
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
